Voyageur Pharmaceuticals Ltd
OTC:VYYRF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Voyageur Pharmaceuticals Ltd (VYYRF) under the Base Case is USD per share.
Compared with the current market price of 0.089 USD, the stock appears .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years.
Create a free account · No card needed
Fundamental Analysis
What Voyageur Pharmaceuticals Does
Voyageur Pharmaceuticals Ltd is a Canadian specialty pharmaceutical company focused on diagnostic imaging products. It works on contrast agents, especially barium-based products used to help doctors see the gastrointestinal tract in X-ray and CT imaging. The company also develops related formulations and mineral-based pharmaceutical ingredients that sit upstream in the medical imaging supply chain.
- Headquarters
- Canada CA
- IPO date
- May 18, 2012
Balance Sheet
Continue VYYRF Research
Decided on Voyageur Pharmaceuticals? Get an email when VYYRF reaches the price you’d buy at. Free with an account.
Other Voyageur Pharmaceuticals listings
What is the Intrinsic Value of one VYYRF stock?
The intrinsic value for
Voyageur Pharmaceuticals Ltd (VYYRF) under the Base Case is USD.
Is VYYRF stock undervalued or overvalued?
Compared with the current market price of 0.089 USD, the stock appears .